✦ LIBER ✦

Efficacy, safety, and gastrointestinal tolerability of tapentadol ER in a randomized, double-blind, placebo- and active-controlled phase III study of patients with chronic low back pain

✍ Scribed by R. Buynak; D. Shapiro; A. Okamoto; C. Lange; M. Etropolski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of tapentadol ER for

✍ R. Buynak; D. Shapiro; A. Okamoto; I. Van Hove; M. Etropolski 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 34 KB

A randomized, double-blind, placebo- and

✍ M. Etropolski; C. Rauschkolb-Löffler; D. Shapiro; A. Okamoto; C. Lange 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Poster 48: Gastrointestinal Tolerability

✍ Douglas Shapiro; Robert Buynak; Mila S. Etropolski; Claudia Lange; Akiko Okamoto 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 52 KB

Efficacy and safety of oxymorphone exten

✍ Martin E. Hale; Chris Dvergsten; Joseph Gimbel 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 180 KB

A randomized, double-blind, placebo-cont

✍ Gerald G. Krueger; Kim A. Papp; Dow B. Stough; Keith H. Loven; Wayne P. Gulliver 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 480 KB

Efficacy and tolerability of tapentadol

✍ A. Vinik; D. Shapiro; C. Rauschkolb-Löffler; B. Lange; K. Karcher; D. Pennett; M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 38 KB